Structure Therapeutics (GPCR) Other Operating Expenses (2025)

Structure Therapeutics (GPCR) recorded quarterly Other Operating Expenses of -$110.2 million in Q4 2025.

Structure Therapeutics (GPCR) Other Operating Expenses (2025) Analysis & Trends

Structure Therapeutics' Other Operating Expenses history runs 1 years deep, the most recent figure standing at -$110.2 million for Q4 2025.

In Q4 2025, Other Operating Expenses changed N/A year-over-year to -$110.2 million; the TTM figure through Mar 2026 stood at -$110.2 million (changed N/A YoY), while the FY2025 annual figure was -$110.2 million, changed N/A from the prior year.
Other Operating Expenses was -$110.2 million for Q4 2025 at Structure Therapeutics.
In the past five years, Other Operating Expenses ranged from a high of -$110.2 million in Q4 2025 to a low of -$110.2 million in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	814,307.08 Bn	814,307.05 Bn	-
2	Belite Bio	55,320.00 Bn	55,320.00 Bn	-
3	Quantum Biopharma	17,149.72 Bn	17,149.72 Bn	-
4	Legend Biotech	3,590.00 Bn	3,589.71 Bn	242.10 Mn
5	Akari Therapeutics	1,650.72 Bn	1,650.72 Bn	-
6	Evaxion A	1,522.09 Bn	1,522.07 Bn	-
7	Psyence Biomedical	229.39 Bn	229.38 Bn	-
8	Vertex Pharmaceuticals	113.09 Bn	105.85 Bn	2.59 Bn
9	Abivax	90.15 Bn	90.15 Bn	-
10	Structure Therapeutics	9.35 Bn	9.35 Bn	-

Download Data

Date	Value
Dec 31, 2025	-110.25 Mn